Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors α and β by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis

被引:15
|
作者
Demyttenaere-Kovatcheva, A
Cronin, MTD
Benfenati, E
Roncaglioni, A
LoPiparo, E
机构
[1] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England
[2] Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
关键词
D O I
10.1021/jm050604j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three-dimensional (31)) quantitative structure-activity relationship (QSAR) and structure-activity relationship (SAR) analyses were applied concurrently to a data set of highly selective estrogen receptor beta (ER beta) agonists. The data set consisted of diphenolic azoles characterized by similar structural skeletons but with different binding modes to the estrogen receptor site. Models were developed separately with respect to the relative binding affinities (RBAs) to ER alpha and ER beta. Steric and electrostatic fields were calculated for a training set of 72 compounds using comparative molecular field analysis (CoMFA). The model developed for ER alpha RBA yielded R-2 of 0.91 and q(cv)(2) of 0.60. The model developed for ER beta RBA yielded R-2 of 0.95 and q(cv)(2) of 0.40. Both models were validated successfully using an external test set of 32 compounds. A new concept of test set evaluation based on the variability of the biological response due to the variability of the living organism has been introduced. The CoMFA analysis was supported by a SAR study. In addition to the most favorable steric and electrostatic regions identified by CoMFA, a number of structural descriptors were identified as being important for binding. These are the number of substituents attached to the main skeleton of each compound, the largest distance between the oxygen atoms of each molecule, and the angle defined by the planes that split the phenyl or the naphthyl and the benzisoxazole or the benzoxazole moiety in a morphometrically longitudinal way.
引用
收藏
页码:7628 / 7636
页数:9
相关论文
共 50 条
  • [31] Three-dimensional quantitative structure-activity relationship analyses of a series of butenolide ETA antagonists
    Zhu, LL
    Xu, XJ
    [J]. CHINESE JOURNAL OF CHEMISTRY, 2003, 21 (03) : 261 - 269
  • [32] Three-dimensional quantitative structure-activity relationship study on antioxidant capacity of curcumin analogues
    Chen, Bohong
    Zhu, Zhibo
    Chen, Min
    Dong, Wenqi
    Li, Zhen
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2014, 1061 : 134 - 139
  • [33] QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP OF ESTROGEN ACTIVITIES OF BISPHENOL A ANALOGS
    CUI Shihai1
    2. College of Chemistry and Environment
    [J]. Science Bulletin, 2006, (03) : 287 - 292
  • [34] Quantitative structure-activity relationship of estrogen activities of bisphenol A analogs
    Cui, SH
    Liu, SS
    Yang, J
    Wang, XD
    Wang, LS
    [J]. CHINESE SCIENCE BULLETIN, 2006, 51 (03): : 287 - 292
  • [35] A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure-activity relationship analysis
    Pastor, M
    Cruciani, G
    Watson, KA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) : 4089 - 4102
  • [36] A Quantitative Structure-Activity Relationship Model
    Zahouily, Mohamed
    Lazar, Mohamed
    Bnoumarzouk, Marouan
    Mouhibi, Rokaya
    Nohair, Mohamed
    Bahlaoui, M. Abdellah
    [J]. CHEMICAL PRODUCT AND PROCESS MODELING, 2008, 3 (01):
  • [37] Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis
    Biegel, Annegret
    Gebauer, Sabine
    Brandsch, Matthias
    Neubert, Klaus
    Thondorf, Iris
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4286 - 4296
  • [38] Three-dimensional quantitative structure-activity relationships for androgen receptor ligands
    Waller, CL
    Juma, BW
    Gray, LE
    Kelce, WR
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 137 (02) : 219 - 227
  • [39] Three-dimensional quantitative structure-activity, relationship modeling of γ-secretase inhibitors using molecular field analysis
    Sammi, Tarnvir
    Silalkari, Om
    Ravikumar, Muttineni
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (02) : 155 - 166
  • [40] Complementary Three-Dimensional Quantitative Structure-Activity Relationship Modeling of Binding Affinity and Functional Potency: A Study on α4β2 Nicotinic Ligands
    Tosco, Paolo
    Ahring, Philip K.
    Dyhring, Tino
    Peters, Dan
    Harpsoe, Kasper
    Liljefors, Tommy
    Balle, Thomas
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2311 - 2316